Mohammed Albratty
- Biomaterials top 5%
- Pharmaceutical Science top 5%
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 7
- Biological Psychiatry top 10%
- Tryptophan and brain disorders 4
-
- Computational Drug Discovery Methods 12
-
- Synthesis and biological activity 11
-
- Natural Antidiabetic Agents Studies 11
-
- Alzheimer's disease research and treatments 8
-
- Cholinesterase and Neurodegenerative Diseases 8
-
- Phytochemistry and Biological Activities 7
- Co-authors
- Hassan A. AlhazmiAbdulkarim M. MerayaAsim NajmiHafiz A. MakeenTapan BehlSimona BungăuSaurabh BhatiaAli Albarrati
- Partner nations
- Saudi ArabiaIndiaRomania
In The Last Decade
Mohammed Albratty
107 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 157
- Biomaterials 245
- Complementary and alternative medicine 129
- Pharmaceutical Science 95
- Biochemistry 90
- Biological Psychiatry 37
Countries citing papers authored by Mohammed Albratty
This map shows the geographic impact of Mohammed Albratty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Albratty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Albratty more than expected).
Fields of papers citing papers by Mohammed Albratty
This network shows the impact of papers produced by Mohammed Albratty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Albratty. The network helps show where Mohammed Albratty may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed Albratty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 20 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 35 | |
| 9 | 2023 | 21 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 26 | |
| 13 | 2023 | 12 | |
| 14 | 2022 | 17 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 42 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 10 | |
| 19 | 2022 | 29 | |
| 20 | 2019 | 37 |
About Mohammed Albratty
Mohammed Albratty is a scholar working on Biological Psychiatry, Biochemistry and Pharmacology, having authored 113 papers that have together received 2.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (12 papers), Synthesis and biological activity (11 papers), Natural Antidiabetic Agents Studies (11 papers), Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers), Phytochemicals and Antioxidant Activities (7 papers), Phytochemistry and Biological Activities (7 papers) and Tryptophan and brain disorders (4 papers). The work is most often cited by research in Biomaterials (245 citations), Complementary and alternative medicine (129 citations) and Pharmaceutical Science (95 citations). Mohammed Albratty has collaborated with scholars based in Saudi Arabia, India and Romania. Frequent co-authors include Hassan A. Alhazmi, Abdulkarim M. Meraya, Asim Najmi, Hafiz A. Makeen, Tapan Behl, Simona Bungău, Saurabh Bhatia, Ali Albarrati, Syam Mohan and Sukhbir Singh.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.